HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

monoclonal antibody TriGem

a monoclonal antibody directed against I17, for the potential treatment of advanced cancers that express the GD2 ganglioside, including melanoma, small-cell lung cancer, neuroblastoma and sarcoma; also has potential for the treatment of psoriasis
Also Known As:
TriGem
Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Razis, Evangelia: 1 article (04/2003)
2. Fountzilas, George: 1 article (04/2003)
3. Gonzalez-Angulo, Ana M: 1 article (10/2002)
4. Orzano, Jennifer A: 1 article (10/2002)
5. Lutzky, Jose: 1 article (10/2002)
6. Foon, K A: 1 article (01/2000)
7. Das, R: 1 article (01/2000)
8. Hutchins, L: 1 article (01/2000)
9. Kashala, O L: 1 article (01/2000)
10. Yannelli, J R: 1 article (01/2000)

Related Diseases

1. Melanoma (Melanoma, Malignant)
2. Psoriasis (Pustulosis Palmaris et Plantaris)
3. Small Cell Lung Carcinoma (Small Cell Lung Cancer)
4. Disease Progression
5. Sarcoma (Soft Tissue Sarcoma)

Related Drugs and Biologics

1. Vaccines
2. QS 21 (QS21)
3. GD2 ganglioside